This inventor holds 1 USPTO granted patent. Top assignee: Adlai Nortye Biopharma Co., Ltd.. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Pingping Lu - Innovator in Cancer Treatment
Introduction
Pingping Lu is a notable inventor based in Hangzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit the Wnt pathway, which is crucial in various diseases.
Latest Patents
Pingping Lu holds 1 patent for a high-activity Wnt pathway inhibitor compound. This patent includes a compound designed to inhibit Wnt pathway activity, along with a pharmaceutical composition that incorporates this compound. The compound is intended for use in the prevention and treatment of cancers, tumors, inflammatory diseases, autoimmune diseases, or immune-mediated diseases.
Career Highlights
Pingping Lu is currently associated with Adlai Nortye Biopharma Co., Ltd., where he continues to work on innovative solutions in the biopharmaceutical sector. His research focuses on developing effective treatments that target critical pathways involved in disease progression.
Collaborations
Pingping Lu collaborates with talented professionals in his field, including Yufeng Chen and Peng Wu. Their combined expertise enhances the research and development efforts at their company.
Conclusion
Pingping Lu's work in developing Wnt pathway inhibitors represents a significant advancement in cancer treatment and other diseases. His contributions to the pharmaceutical industry are paving the way for innovative therapeutic options.